<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">NORMAL SERUM ALBUMIN, HUMAN <img border="0" src="../images/pr.gif"/></span><br/>(al-byoo'min)<br/><span class="topboxtradename">Albuminar, </span><span class="topboxtradename">Albutein, </span><span class="topboxtradename">Buminate, </span><span class="topboxtradename">Plasbumin<br/></span><b>Classifications:</b> <span class="classification">blood formers, coagulators, and anticoagulants</span>; <span class="classification">blood derivative</span>; <span class="classification">plasma volume expander</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>5%, 25% injection</p>
<h1><a name="action">Actions</a></h1>
<p>Obtained by fractionating pooled venous and placental human plasma, which is then sterilized by filtration and heat to minimize
         possibility of transmitting hepatitis B virus or HIV. Risk of sensitization is reduced because it lacks cellular elements
         and contains no coagulation factors, Rh factor, or blood group antibodies.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Expands volume of circulating blood by osmotically shifting tissue fluid into general circulation.</p>
<h1><a name="uses">Uses</a></h1>
<p>To restore plasma volume and maintain cardiac output in hypovolemic shock; for prevention and treatment of cerebral edema;
         as adjunct in exchange transfusion for hyperbilirubinemia and erythroblastosis fetalis; to increase plasma protein level in
         treatment of hypoproteinemia; and to promote diuresis in refractory edema. Also used for blood dilution prior to or during
         cardiopulmonary bypass procedures. Has been used as adjunct in treatment of adult respiratory distress syndrome (ARDS).
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Severe anemia; cardiac failure, patients with normal or increased intravascular volume. Safety during pregnancy (category
         C) or lactation is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Low cardiac reserve, pulmonary disease, absence of albumin deficiency; liver or kidney failure, dehydration, hypertension,
         restricted sodium intake.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Emergency Volume Replacement</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 25 g, may repeat in 1530 min if necessary (max: 250 g)<br/><br/><span class="indicationtitle">Colloidal Volume Replacement (Nonemergency)</span><br/><span class="rdage">Child:</span> <span class="rdroute">IV</span> 12.5 g, may repeat in 1530 min if necessary<br/><br/><span class="indicationtitle">Hyperbilirubinemia, Erythroblastosis Fetalis</span><br/><span class="rdage">Child:</span> <span class="rdroute">IV</span> 1 g/kg of 25% solution 12 h before transfusion<br/><br/><span class="indicationtitle">Hypoproteinemia Prophylaxis in Neonates</span><br/><span class="rdage">Child:</span> <span class="rdroute">IV</span> 1.41.8 mL/kg of 25% solution<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><ul>
<li>
                     					Note: 5% solution = 5 g/100 mL; 25% solution = 25 g/mL.
                     				
                  </li>
</ul>
<p><span class="routemethod">PREPARE:</span> <span class="methodtype">IV Infusion:</span>  Normal serum albumin, 5%, is infused without further dilution. Normal serum albumin, 25%, may be infused undiluted
                  or diluted in NS or D5W (with sodium restriction).  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">IV Infusion: Hypovolemic Shock:</span> Give initially as rapidly as necessary to restore blood volume. As blood volume approaches normal, rate should be reduced
                  to avoid circulatory overload and pulmonary edema. Give 5% albumin at rate not exceeding 24 mL/min. Give 25%
                  albumin at a rate not to exceed 1 mL/min.  <span class="methodtype">With Normal Blood Volume:</span>  Give 5% albumin human at a rate not to exceed 510 mL/min; give 25% albumin at a rate not to exceed 2 or 3 mL/min.  <span class="methodtype">Children:</span> Usual rate is <small>1/4</small>½ the adult rate.  
               </p>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span>
<b>Verapamil.</b>
<span class="incompattype">Y-site:</span>
<b>Midazolam,</b>
<b>vancomycin,</b>
<b>verapamil.</b>
</p>
</td>
</tr>
</table>
<ul>
<li>Store at temperature not to exceed 37° C (98.6° F).</li>
<li>Use solution within 4 h, once container is opened, because it contains no preservatives or antimicrobials. Discard unused
            portion.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Fever, chills, flushing, increased salivation, headache, back pain. <span class="typehead">Skin:</span> Urticaria, rash. <span class="typehead">CV:</span> Circulatory overload, pulmonary edema (with rapid infusion); hypotension, hypertension, dyspnea, tachycardia. <span class="typehead">GI:</span> Nausea, vomiting. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>False rise in <span class="alt">alkaline phosphatase</span> when albumin is obtained partially from pooled placental plasma (levels reportedly decline over period of weeks).
      </p>
<h1><a name="interactions">Interactions</a></h1>No clinically significant interactions established. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor BP, pulse and respiration, and IV albumin flow rate. Adjust flow rate as needed to avoid too rapid a rise in BP.</li>
<li>Lab tests: Monitor dosage of albumin using plasma albumin (normal): 3.55 g/dL; total serum protein (normal): 68.4
            g/dL; Hgb; Hct; and serum electrolytes.
         </li>
<li>Observe closely for S&amp;S of circulatory overload and pulmonary edema (see Appendix F). If S&amp;S appear, slow infusion rate just
            sufficiently to keep vein open, and report immediately to physician.
         </li>
<li>Observe for bleeding points that did not bleed at lower BP with injuries or surgery and as BP rises.</li>
<li>Monitor I&amp;O ratio and pattern. Report changes in urinary output. Increase in colloidal osmotic pressure usually causes diuresis,
            which may persist 320 h.
         </li>
<li>Withhold fluids completely during succeeding 8 h, when albumin is given to patients with cerebral edema.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report chills, nausea, headache, or back pain to physician immediately.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>